DrugDashboards

Levocetirizine Dihydrochloride

Levocetirizine Dihydrochloride · LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1 · Tablet, Film Coated · Oral · Teva Pharmaceuticals USA, Inc.

NDC 00093-7701-98 · 90 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

22 companies supply this market — deep enough that no single failure threatens the supply. The price is down 14% over the past year, to $0.0517 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0517per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.2097per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0993per TABweighted avg manufacturer price $0.0537 · Mar 1, 2019192% of what pharmacies pay — higher than 86% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Nov 2013Sep 2026$0.0517
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$1.55
#90 count
$4.65

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$592,158
56,212 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for levocetirizine dihydrochloride (oral solid) in the next 90 days

sole-source market · price up 6% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA090199
TE code
AB
Approval date
Aug 22, 2011
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Levocetirizine Dihydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Amazon.com Services LLCLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Camber Consumer Care IncLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Chattem, Inc.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Dolgencorp, LLCLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Farmacias De Similares TX LLCLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
L. Perrigo CompanyLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals IncLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Meijer Distribution IncLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Micro Labs LimitedLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Rite Aid CorporationLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Sportpharm LLCLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Topco Associates LLCLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
UCB Farchim S.A.LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Walgreen CompanyLEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Levocetirizine Dihydrochloride — NDC 00093-7701-98," retrieved September 3, 2026, https://drugdashboards.com/drug/00093770198.

Free to cite with attribution — see how the data is put together.